Pharmalive - The Pulse of the Pharmaceutical Industry
Search Criteria: Search In:  
Conferences


Pharma Blog Review By Chris Truelove

Archive for the ‘ Uncategorized ’ Category

Happy new year, sort of

Friday, January 15th, 2010

Yes, the Pharma Blog Week in Review is back. I had to take a break from it over the holidays; I even became so silent on Twitter that I had a few folks ask me if I was all right. But I knew I'd get back into the swing of ...

J&J job cuts kick off week

Friday, November 6th, 2009

It's a mixed bag this week in pharma industry news (much like that sack of your kids hauled home from their trick-or-treating, for every KitKat, there's a bag of candy corn). Some of the notable items: Johnson & Johnson announced the company would be reducing its headcount by ...

For Halloween, some bloggy treats (no tricks)

Friday, October 30th, 2009

Halloween is tomorrow, but for the pharmaceutical industry, the real "party" will be November's two-day meeting on social media use, sponsored by FDA. Everyone is hoping the hearing will yield a treat (in the form of a workable guidance on social media) and not tricks (in the form of FDA ...

Pharma still uneasy about getting social

Friday, October 23rd, 2009

This week was full and frantically busy, and I am not just talking about the three days I drove back and forth to Bridgewater, N.J., for ExL Pharma's Digital Pharma conference (if you want the quick lowdown on what happened there, you can find the Tweets, from me and many ...

Pfizer pfuels burst of blogger speculation

Friday, October 16th, 2009

The week ended in a big way, as Pfizer's acquisition of Wyeth became final and FDA approved GlaxoSmithKline's Cervarix vaccine for cervical cancer. Also, debate continued about the healthcare reform bill passed by the Senate Finance Committee last week. And fortunately for the industry, no recent bombs about ghostwriting or ...

Catching up, after vacation

Friday, October 9th, 2009

Now that I'm back in the office from my Boston vacation (and a very interesting visit last Monday with Jeff Porter, Tim Wright, and Mark Fishman of Novartis Institutes for Biomedical Research, which I will be writing about in January's R&D Directions), I have some stuff to catch up on. ...

   
©2010 Canon Communications Pharmaceutical Media Group